CD40LG and COVID-19: A total of 88% (103 out of 117) of participants had a positive COVID-19 IgM in the first visit and after six months follow up 53.9% (41 out of 76) participants had a positive COVID-19 IgM and the difference was statistically significant (p<0.05) (Table 1).